154 related articles for article (PubMed ID: 27749545)
1. The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists.
Cockerell CJ; Tschen J; Evans B; Bess E; Kidd J; Kolquist KA; Rock C; Clarke LE
Medicine (Baltimore); 2016 Oct; 95(40):e4887. PubMed ID: 27749545
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
3. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.
Clarke LE; Flake DD; Busam K; Cockerell C; Helm K; McNiff J; Reed J; Tschen J; Kim J; Barnhill R; Elenitsas R; Prieto VG; Nelson J; Kimbrell H; Kolquist KA; Brown KL; Warf MB; Roa BB; Wenstrup RJ
Cancer; 2017 Feb; 123(4):617-628. PubMed ID: 27768230
[TBL] [Abstract][Full Text] [Related]
4. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
5. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma.
Clarke LE; Warf MB; Flake DD; Hartman AR; Tahan S; Shea CR; Gerami P; Messina J; Florell SR; Wenstrup RJ; Rushton K; Roundy KM; Rock C; Roa B; Kolquist KA; Gutin A; Billings S; Leachman S
J Cutan Pathol; 2015 Apr; 42(4):244-52. PubMed ID: 25727210
[TBL] [Abstract][Full Text] [Related]
6. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
7. Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
Castillo SA; Pham AK; Dagrosa AT; Yan S; Barton DT; Lefferts JA; Linos K
Am J Dermatopathol; 2020 Dec; 42(12):939-947. PubMed ID: 32675469
[TBL] [Abstract][Full Text] [Related]
8. Correlation of melanoma gene expression score with clinical outcomes on a series of melanocytic lesions.
Ko JS; Clarke LE; Minca EC; Brown K; Flake DD; Billings SD
Hum Pathol; 2019 Apr; 86():213-221. PubMed ID: 30566894
[TBL] [Abstract][Full Text] [Related]
9. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?
Braun RP; Gutkowicz-Krusin D; Rabinovitz H; Cognetta A; Hofmann-Wellenhof R; Ahlgrimm-Siess V; Polsky D; Oliviero M; Kolm I; Googe P; King R; Prieto VG; French L; Marghoob A; Mihm M
Dermatology; 2012; 224(1):51-8. PubMed ID: 22433231
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of dermoscopy improves inter-observer agreement among dermatopathologists in histologic assessment of melanocytic neoplasms.
Shi K; Compres E; Walton KE; Mohan LS; Zhang B; Panah E; Quan VL; Garfield EM; Khan AU; Kim D; Yazdan P; Robinson JK; Gerami P
Arch Dermatol Res; 2021 Mar; 313(2):101-108. PubMed ID: 32338293
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
[TBL] [Abstract][Full Text] [Related]
12. The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions.
Cockerell C; Tschen J; Billings SD; Evans B; Brown K; Rock C; Clarke LE
Per Med; 2017 Mar; 14(2):123-130. PubMed ID: 28757886
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
15. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
Lezcano C; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
[TBL] [Abstract][Full Text] [Related]
17. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms.
Clarke LE; Mabey B; Flake Ii DD; Meek S; Cassarino DS; Duncan LM; High WA; Napekoski KM; Prieto VG; Tetzlaff MT; Vitale P; Elder DE
Per Med; 2020 Sep; 17(5):361-371. PubMed ID: 32915688
[No Abstract] [Full Text] [Related]
18. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
19. Association of Clinical, Dermoscopic, and Histopathologic Findings With Gene Expression in Patients With Balloon Cell Melanoma.
Friedman BJ; Stoner R; Sahu J; Lee JB
JAMA Dermatol; 2018 Jan; 154(1):77-81. PubMed ID: 29238799
[TBL] [Abstract][Full Text] [Related]
20. Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting.
Becker B; Roesch A; Hafner C; Stolz W; Dugas M; Landthaler M; Vogt T
J Invest Dermatol; 2004 Feb; 122(2):361-8. PubMed ID: 15009717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
